Low Transfer of Tacrolimus and Its Metabolites into Colostrum of Graft Recipient Mothers

Overview

Journal Nutrients

Date 2018 Mar 3

PMID 29495430

Citations 4

Authors

Bozena Kociszewska-Najman

Natalia Mazanowska

Bronislawa Pietrzak

Leszek Paczek

Monika Szpotanska-Sikorska

Joanna Schreiber-Zamora

Ewa Hryniewiecka

Dorota Zochowska

Emilia Samborowska

Michal Dadlez

Miroslaw Wielgos

Affiliations

Soon will be listed here.

Abstract

Currently, the majority of neonates born to organ recipient mothers on chronic immunosuppressive therapy are formula fed. However, over the past few years, evidence has grown, suggesting that breastfeeding might be possible and beneficial. We designed a study assessing the transfer of tacrolimus into the colostrum of posttransplant mothers. We assessed the amount of tacrolimus and its metabolites, M-1 and M-3, that would be ingested by the breastfed neonates. Concentrations of tacrolimus and its metabolites were measured in colostrum from 14 posttransplant mothers as well as in venous cord blood and venous blood of the neonates. Test material analysis was performed by liquid chromatography coupled with mass spectrometry (LC/MS). The amount of ingested formula was registered, which allowed for estimation of the amount of tacrolimus and its metabolites that would be ingested by breastfed infants. The mean amount of tacrolimus that would be ingested by the neonates in maternal milk was 151.4 ng/kg/24 h (standard deviation SD ± 74.39); metabolite M-1: 23.80 ng/kg/24 h (SD ± 14.53); and metabolite M-3: 13.25 ng/kg/24 h (SD ± 9.05). The peak level of tacrolimus and metabolite M-1 in colostrum was noted 8 h after an oral dose (3.219 ng/mL SD ± 2.22 and 0.56 ng/mL SD ± 0.60, respectively) and metabolite M-3 after 6 h (0.29 ng/mL SD ± 0.22). Low concentrations of tacrolimus and its metabolites, M-1 and M-3, in colostrum show that neonates will ingest trace amounts of the drug. Further studies are required to fully assess the safety of breastfeeding by posttransplant mothers.

Citing Articles

Drugs in Human Milk Part 1: Practical and Analytical Considerations in Measuring Drugs and Metabolites in Human Milk.

Alshogran O, Dodeja P, Albukhaytan H, Laffey T, Chaphekar N, Caritis S Clin Pharmacokinet. 2024; 63(5):561-588.

PMID: 38748090 DOI: 10.1007/s40262-024-01374-3.

British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroids.

Russell M, Dey M, Flint J, Davie P, Allen A, Crossley A Rheumatology (Oxford). 2022; 62(4):e48-e88.

PMID: 36318966 PMC: 10070073. DOI: 10.1093/rheumatology/keac551.

Breastfeeding and Medication Use in Kidney Disease.

Singh M Adv Chronic Kidney Dis. 2020; 27(6):516-524.

PMID: 33328068 PMC: 7211684. DOI: 10.1053/j.ackd.2020.05.007.

Low Content of Cyclosporine A and Its Metabolites in the Colostrum of Post-Transplant Mothers.

Kociszewska-Najman B, Mazanowska N, Borek-Dzieciol B, Paczek L, Samborowska E, Szpotanska-Sikorska M Nutrients. 2020; 12(9).

PMID: 32899873 PMC: 7551077. DOI: 10.3390/nu12092713.

References

Lopez L, Martinez C, Castaneda D, Hernandez A, Perez H, Lozano E . Pregnancy and kidney transplantation, triple hazard? Current concepts and algorithm for approach of preconception and perinatal care of the patient with kidney transplantation. Transplant Proc. 2014; 46(9):3027-31. DOI: 10.1016/j.transproceed.2014.07.013. View

Lawrence R . Infection, allergy, and the protection from breastfeeding. Breastfeed Med. 2009; 4(1):1-2. DOI: 10.1089/bfm.2009.9999. View

Zegarska J, Hryniewiecka E, Zochowska D, Samborowska E, Jazwiec R, Borowiec A . Tacrolimus Metabolite M-III May Have Nephrotoxic and Myelotoxic Effects and Increase the Incidence of Infections in Kidney Transplant Recipients. Transplant Proc. 2016; 48(5):1539-42. DOI: 10.1016/j.transproceed.2015.12.133. View

. American Academy of Pediatrics Committee on Drugs: Transfer of drugs and other chemicals into human milk. Pediatrics. 1989; 84(5):924-36. View

Levy R, de Jesus G, de Jesus N, Klumb E . Critical review of the current recommendations for the treatment of systemic inflammatory rheumatic diseases during pregnancy and lactation. Autoimmun Rev. 2016; 15(10):955-63. DOI: 10.1016/j.autrev.2016.07.014. View

. European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.10. Pregnancy in renal transplant recipients. Nephrol Dial Transplant. 2002; 17 Suppl 4:50-5. View

Zheng S, Easterling T, Hays K, Umans J, Miodovnik M, Clark S . Tacrolimus placental transfer at delivery and neonatal exposure through breast milk. Br J Clin Pharmacol. 2013; 76(6):988-96. PMC: 3845323. DOI: 10.1111/bcp.12122. View

Gartner L, Morton J, Lawrence R, Naylor A, OHare D, Schanler R . Breastfeeding and the use of human milk. Pediatrics. 2005; 115(2):496-506. DOI: 10.1542/peds.2004-2491. View

Tszyrsznic W, Borowiec A, Pawlowska E, Jazwiec R, Zochowska D, Bartlomiejczyk I . Two rapid ultra performance liquid chromatography/tandem mass spectrometry (UPLC/MS/MS) methods with common sample pretreatment for therapeutic drug monitoring of immunosuppressants compared to immunoassay. J Chromatogr B Analyt Technol Biomed Life Sci. 2013; 928:9-15. DOI: 10.1016/j.jchromb.2013.03.014. View

10.

Thiagarajan K, Arakali S, Mealey K, Cardonick E, Gaughan W, Davison J . Safety considerations: breastfeeding after transplant. Prog Transplant. 2013; 23(2):137-46. DOI: 10.7182/pit2013803. View

11.

Sisk P, Lovelady C, Dillard R, Gruber K, OShea T . Early human milk feeding is associated with a lower risk of necrotizing enterocolitis in very low birth weight infants. J Perinatol. 2007; 27(7):428-33. DOI: 10.1038/sj.jp.7211758. View

12.

Gouraud A, Bernard N, Millaret A, Bruel M, Paret N, Descotes J . Follow-up of tacrolimus breastfed babies. Transplantation. 2012; 94(6):e38-40. DOI: 10.1097/TP.0b013e3182654d36. View

13.

Rollins N, Bhandari N, Hajeebhoy N, Horton S, Lutter C, Martines J . Why invest, and what it will take to improve breastfeeding practices?. Lancet. 2016; 387(10017):491-504. DOI: 10.1016/S0140-6736(15)01044-2. View

14.

. Breastfeeding and the use of human milk. Pediatrics. 2012; 129(3):e827-41. DOI: 10.1542/peds.2011-3552. View

15.

Bernick S, Kane S . Drug transfer to the fetus and to the breastfeeding infant: what do we know?. Curr Drug Deliv. 2012; 9(4):350-5. DOI: 10.2174/156720112801323116. View

16.

Arslanoglu S, Corpeleijn W, Moro G, Braegger C, Campoy C, Colomb V . Donor human milk for preterm infants: current evidence and research directions. J Pediatr Gastroenterol Nutr. 2013; 57(4):535-42. DOI: 10.1097/MPG.0b013e3182a3af0a. View

17.

Sachs H . The transfer of drugs and therapeutics into human breast milk: an update on selected topics. Pediatrics. 2013; 132(3):e796-809. DOI: 10.1542/peds.2013-1985. View

18.

Boyd C, Quigley M, Brocklehurst P . Donor breast milk versus infant formula for preterm infants: systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed. 2006; 92(3):F169-75. PMC: 2675323. DOI: 10.1136/adc.2005.089490. View

19.

Gardiner S, Begg E . Breastfeeding during tacrolimus therapy. Obstet Gynecol. 2006; 107(2 Pt 2):453-5. DOI: 10.1097/01.AOG.0000164052.66219.c7. View

20.

Armenti V, Moritz M, Davison J . Breastfeeding and tacrolimus: is it a reasonable approach?. Expert Rev Clin Immunol. 2013; 9(7):623-6. DOI: 10.1586/1744666X.2013.811042. View